EluNIR Ridaforolimus Eluting Coronary Stent System LUN275R20USRecalls & reported problems
Medinol Ltd. · Class 3 · Implant
All models of EluNIR Ridaforolimus Eluting Coronary Stent System (27)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07290107013635), received between May 3, 2018 and May 3, 2018 — classified as 1 malfunction.
The most frequently reported specific device problem is “Material Deformation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Material Deformation1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 3, 2018Material Deformation; Material Deformation
THE TECH REMOVED STENT FROM STERILE PACKAGING. UPON EXAMINING THE STENT BEFORE INSERTION, THE TECH NOTICED THAT STENT HAD A MALFORMATION. A STENT STRUT HAD FRACTURED AND WAS STICKING OUT FROM BODY OF THE STENT. THE PHYSICIAN TOOK A CLEAN DRY GAUZE AND RAN IT BACK THE STENT TO SEE IF THE STRUT WAS PART OF THE STENT. THE MALFORMATION STRUT GRABBED THE GAUZE AND THE PHYSICIAN DID NOT USE THE STENT. ADDITIONAL INFORMATION RECEIVED ON APRIL 11TH, 2018: NO EXCESSIVE FORCE WAS APPLIED TO THE DEVICE DURING PREPARATION. THE TECH DID NOT TOUCH THE STENT AREA. THE STENT WAS DAMAGED APPROXIMATELY IN THE MIDDLE OF IT. THE PRODUCT WAS STORED PROPERLY, ACCORDING TO IFU. THE PACKAGING WAS INSPECTED PRIOR TO USE AND NO DAMAGE WAS NOTED. THERE WAS NO DIFFICULTY REMOVING THE PRODUCT FROM THE PACKAGING.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7482397 ↗
Other Coronary Drug-Eluting Stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page